[Federal Register Volume 63, Number 1 (Friday, January 2, 1998)] [Notices] [Page 61] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 97-34201] ----------------------------------------------------------------------- DEPARTMENT OF DEFENSE Department of the Navy Notice of Intent to Grant Exclusive Patent License; U.S. Drug Testing, Inc. AGENCY: Department of the Navy, DoD. ACTION: Notice of intent to grant exclusive license. ----------------------------------------------------------------------- SUMMARY: The Department of the Navy hereby gives notice of its intent to grant to U.S. Drug Testing, Inc., a revocable, nonassignable, exclusive license in the United States and certain foreign countries to practice the Government owned invention described in U.S. Patent No. 5,183,740, entitled ``Flow Immunosensor Method and Apparatus,'' issued February 2, 1993, in the field of saliva based human diagnostics. DATES: Anyone wishing to object to the grant of this license must file written objections, along with any supporting evidence, not later than March 3, 1998. ADDRESSES: Written objections are to be filed with the Office of Naval Research, ONR 00CC, Ballston Tower One, 800 North Quincy Street, Arlington, Virginia 22217-5660. FOR FURTHER INFORMATION CONTACT: Mr. R. J. Erickson, Staff Patent Attorney, Office of Naval Research, ONR 00CC, Ballston Tower One, 800 North Quincy Street, Arlington, Virginia 22217-5660, telephone (703) 696-4001. Authority: 35 U. S. C. 207; 37 CFR Part 404; 32 CFR Part 746. Dated: December 19, 1997. Michael I. Quinn, Lieutenant Commander, Judge Advocate General's Corps, U. S. Navy, Alternate Federal Register Liaison Officer. [FR Doc. 97-34201 Filed 12-31-97; 8:45 am] BILLING CODE 3810-FF-P